Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tobramycin (nebcin) (2 trials)
Cystic Fibrosis (Phase 2)
Fibrosis (Phase 2)
Trials (2 total)
Trial APIs (1 total)